Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162052 · ClinicalTrials.gov registry record · NA

Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery

A NA study of Burns, sponsored by The University of Texas Medical Branch, Galveston.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06162052: Recruiting NA study of Burns, sponsored by The University of Texas Medical Branch, Galveston.

NCT06162052 is a NA study of Burns that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 30 participants, below the 82-participant average among 36 other Burns trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162052, a NA study of Burns, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effect of participating in a tele-rehabilitation program after a burn.

Primary Outcome

Patient will be asked to bend the affected joint, and the goniometer held next to the joint to measure the angle. The range of motion for the opposite joint will be measured as well.

Conditions Studied

Interventions

  • OTHER Tele-Rehabilitation

Study Locations (1)

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-02
Est. Completion 2027-12
Phase NA

What NCT06162052 shows while recruiting

NCT06162052 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 82-participant average among 36 other Burns trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Burns appearing as the primary indexed condition, and to 1 intervention - of which Tele-Rehabilitation is the first listed.

NCT06162052 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06162052 about?

NCT06162052 is a clinical study titled "Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery". The purpose of this study is to examine the effect of participating in a tele-rehabilitation program after a burn.

What is the current status of trial NCT06162052?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-02. Estimated completion is 2027-12.

What conditions does trial NCT06162052 study?

This clinical trial studies the following conditions: Burns.

What interventions are being tested in trial NCT06162052?

The interventions under investigation include: Tele-Rehabilitation (OTHER).

Who is sponsoring clinical trial NCT06162052?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162052 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burns

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06162052's enrollment target sits among peer trials

30 16th of 36 higher than 20 of 36 other Burns trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Burns trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06162052, the US trial registry maintained by the National Library of Medicine. NCT06162052 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.